Fiera Capital Corp Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fiera Capital Corp lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,612,780 shares of the healthcare conglomerate’s stock after selling 161,343 shares during the period. UnitedHealth Group makes up 2.6% of Fiera Capital Corp’s portfolio, making the stock its 8th biggest position. Fiera Capital Corp’s holdings in UnitedHealth Group were worth $815,841,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of UNH. Hidden Cove Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $214,000. Naples Global Advisors LLC increased its holdings in UnitedHealth Group by 3.0% during the 4th quarter. Naples Global Advisors LLC now owns 14,468 shares of the healthcare conglomerate’s stock worth $7,319,000 after purchasing an additional 428 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of UnitedHealth Group by 12.6% in the fourth quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate’s stock valued at $99,607,000 after purchasing an additional 22,059 shares in the last quarter. Retirement Guys Formula LLC grew its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Retirement Guys Formula LLC now owns 4,096 shares of the healthcare conglomerate’s stock worth $2,072,000 after buying an additional 41 shares in the last quarter. Finally, Marks Group Wealth Management Inc boosted its position in UnitedHealth Group by 2.4% during the 4th quarter. Marks Group Wealth Management Inc now owns 31,226 shares of the healthcare conglomerate’s stock worth $15,796,000 after acquiring an additional 720 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $527.31 on Thursday. The company has a market cap of $485.27 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.45 and a beta of 0.61. The stock has a fifty day moving average price of $526.25 and a 200-day moving average price of $563.96. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company earned $5.83 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.